Home > List All Publishers > Valid Results Incorporated
Valid Results IncorporatedSince 2000 Valid Results, Inc. has been providing business intelligence for the medical device industry utilizing published, scientific methodologies to ensure reliable and statistically defensible results. Over the years we have developed a thorough comprehension of the issues and business challenges in the medical device market; however, our dedication to understanding the behaviors, attitudes and perceptions of your customers sets our company apart. |
 |
List of reports from Valid Results Incorporated
|
Contraceptive Devices: Improving Birth Control Device Manufacturers, Sales Rep Performance
4/1/2008 | published by: Valid Results Incorporated
... reps for increasing the value of the information they present as well as provides a position relative to that of their competitors. Sales departments will find this information useful for validating their internal perceptions of ...
|
more...
|
$2,000.00
|
|
Contraceptive Devices: Improving Professional Education Events for OB/Gyn’s Specializing in Birth Control Procedures
4/1/2008 | published by: Valid Results Incorporated
... professional education coordinators to increase the value of the information they present as well as provides a position relative to that of their competitors. Professional Education Managers will find this information useful when attempting to ...
|
more...
|
$2,000.00
|
|
Contraceptive Devices: Gap Analysis - Opportunities and Threats in the Contraceptive Device Market
4/1/2008 | published by: Valid Results Incorporated
... by looking at the importance Ob/Gyn surgeons place on various treatment options, the overall performance of current alternatives and the relative importance of the featured products. Please note that the analysis for this report is ...
|
more...
|
$4,000.00
|
|
Abnormal Uterine Bleeding: Analysis of the Ob/Gyn Market Dynamics and Future Trends Among Leading Global Endometrial Ablation Systems
4/1/2008 | published by: Valid Results Incorporated
... the future trends for use of the featured devices. Devices featured in the questionnaire are: Her Option (American Medical Systems), HydroThermAblator (Boston Scientific), NovaSure (Cytyc/Hologic), THERMACHOICE (Gynecare/Ethicon Women's Health, and the MEA Microwave Endometrial Ablation ...
|
more...
|
$2,000.00
|
|
Abnormal Uterine Bleeding: An Identification and Quantification of the Evaluation Criteria Used by Ob/Gyn Surgeons to Evaluate Global Endometrial Ablation Companies
4/1/2008 | published by: Valid Results Incorporated
... evaluation processes of various obstetrics and gynecology segments, including those who specialize in AUB patients, AUB procedures and/or GEA procedures. Provides an understanding of how company images and positioning evolve. Please note that the analysis ...
|
more...
|
$3,000.00
|
|
Abnormal Uterine Bleeding: How Competing GEA Companies are Positioned in the Minds of Ob/Gyn Surgeons
4/1/2008 | published by: Valid Results Incorporated
... HydroThermAblator (Boston Scientific), NovaSure (Cytyc/Hologic), THERMACHOICE (Gynecare/Ethicon Women's Health, and the MEA Microwave Endometrial Ablation (Microsulis). Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 ...
|
more...
|
$2,500.00
|
|
Abnormal Uterine Bleeding: Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers
4/1/2008 | published by: Valid Results Incorporated
... of a each product's customers that may be at risk. Risk is evaluated by segmenting GEA customers who use a given product but whose needs will better met by a competitive product. Opportunities are supported ...
|
more...
|
$4,000.00
|
|
Oral Contraception and Hormone Therapy: Investigating the Dynamics of Brand Use - An Analysis of Switching, Exclusive Use and Future Trends in Obstetrics/Gynecology
4/1/2008 | published by: Valid Results Incorporated
... competitive brands. Explore the underlying factors explaining the dynamics. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$2,000.00
|
|
Oral Contraception and Hormone Therapy: Assessing the Strength of Associations Between Brands and Their Manufacturer
4/1/2008 | published by: Valid Results Incorporated
... associated with. Featured companies include: Barr, Berlex, Organon, Ortho McNeil, Pfizer, Warner Chilcott, Watson and Wyeth. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 ...
|
more...
|
$2,000.00
|
|
Oral Contraception and Hormone Therapy: Revealing Opportunities and Threats in Obstetrics and Gynecology Through Gap Analysis
4/1/2008 | published by: Valid Results Incorporated
... Organon, Ortho McNeil, Pfizer, Warner Chilcott, Watson and Wyeth. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$4,000.00
|
|
Abnormal Uterine Bleeding: Trends in Procedures for the Treatment of AUB
4/1/2008 | published by: Valid Results Incorporated
... surgery center, office, etc.). Also included is a detailed segmentation analysis comparing minimally invasive AUB specialists, open AUB specialists, general AUB specialists and surgeons performing a low volume of AUB procedures. Please note that the ...
|
more...
|
$2,000.00
|
|
Oral Contraception and Hormone Therapy: Investigating the Dynamics of Brand Use - An Analysis of Switching, Exclusive Use and Future Trends in Obstetrics/Gynecology
4/1/2008 | published by: Valid Results Incorporated
... competitive brands. Explore the underlying factors explaining the dynamics. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$900.00
|
|
The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency
4/1/2008 | published by: Valid Results Incorporated
... and other business functions. Why purchase this report? Determine the potential for pharmaceutical treatments in the Obstetrics and Gynecology market, including AUB hormone therapy and birth control therapy / contraceptives, by gaining knowledge of treatment ...
|
more...
|
$25,000.00
|
|
Contraceptive Devices: Treatment Characteristics of Obstetrics and Gynecology Surgeons Specializing in Birth Control Procedures
4/1/2008 | published by: Valid Results Incorporated
... of birth control and identifies various segments' propensity to grant the requests of the patients. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business ...
|
more...
|
$1,500.00
|
|
Contraceptives: Market Dynamics - Adoption, Switching and Cross Use Trends Among Ob/Gyn’s in the Birth Control Device Market
4/1/2008 | published by: Valid Results Incorporated
... the trends in this area helps companies to identify the opportunities the market is presenting as well as mitigating possible threats. Please note that the analysis for this report is customized. Therefore, the report will ...
|
more...
|
$2,000.00
|
|
Contraceptive Devices: How is the Performance of Contraceptive Device Manufacturers Perceived by Ob/Gyn Surgeons?
4/1/2008 | published by: Valid Results Incorporated
... data, Business assistance (marketing, advertising), Breadth of product line and Product value. The report also provides strategies to contraceptive device manufacturers to boost customer loyalty by providing recommendations for sales and marketing on which product ...
|
more...
|
$3,000.00
|
|
Abnormal Uterine Bleeding: Patient Characteristics and Treatment Modalities Associated with AUB
4/1/2008 | published by: Valid Results Incorporated
... race, etc.). The reader will discover the size of a patient segment that is untapped due to needs not being met by currently available treatment alternatives. Please note that the analysis for this report is ...
|
more...
|
$2,000.00
|
|
Abnormal Uterine Bleeding: Applying the 80/20 Rule to AUB Procedures
4/1/2008 | published by: Valid Results Incorporated
... surgeons to uncover the characteristics of these AUB "specialists." Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$2,000.00
|
|
Abnormal Uterine Bleeding: An Evaluation of Sales Reps Among Global Endometrial Ablation Competitors.
4/1/2008 | published by: Valid Results Incorporated
... (THERMACHOICE), and Microsulis (MEA Microwave Endometrial Ablation). The information provides an objective means to evaluate sales reps within the same product category, and provides insight into the characteristics of surgeons that each company is targeting ...
|
more...
|
$2,000.00
|
|
Abnormal Uterine Bleeding: How do Ob/Gyn Surgeons Who Perform Global Endometrial Ablation Procedures Prefer to be Trained and Educated on New Products, Procedures and Methods?
4/1/2008 | published by: Valid Results Incorporated
... the differences in their training and educational preferences. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order. ...
|
more...
|
$1,500.00
|
|
Abnormal Uterine Bleeding: Considerations that Shape Product Preferences in Obstetrics and Gynecology
4/1/2008 | published by: Valid Results Incorporated
... segments differ in their perceptions of the importance of various considerations that shape their product preferences. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 ...
|
more...
|
$3,000.00
|
|
Abnormal Uterine Bleeding: Assessing the Strengths of Associations Between GEA Brands and their Manufacturers
4/1/2008 | published by: Valid Results Incorporated
... company brand? This report compares the relative strengths of brand-manufacturer associations from a variety of perspectives, comparing companies and products as well as segments of surgeons (i.e. compares customers vs. noncustomers for featured GEA products, ...
|
more...
|
$2,000.00
|
|
Oral Contraception and Hormone Therapy: Evaluating the Effectiveness of Sales Reps in Obstetrics and Gynecology
4/1/2008 | published by: Valid Results Incorporated
... Ortho McNeil, Pfizer, Warner Chilcott, Watson and Wyeth reps. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$2,000.00
|
|
Oral Contraception and Hormone Therapy: Improving the Efficiency of Training and Education Methods to Meet the Needs of Ob/Gyn Surgeons
4/1/2008 | published by: Valid Results Incorporated
... required for increased efficiencies and success among targeted groups. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$1,500.00
|
|
Oral Contraception and Hormone Therapy: What Considerations Shape Preferences in Obstetrics and Gynecology?
4/1/2008 | published by: Valid Results Incorporated
... how they differ in the importance of various considerations. Please note that the analysis for this report is customized. Therefore, the report will be delivered 3 - 5 business days from receipt of an order.
|
more...
|
$3,500.00
|
